Edgewise Therapeutics Announces Upcoming Podium Presentation at the American College of Cardiology s 2024 Annual Scientific Session marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Edgewise Therapeutics Inc. (Nasdaq: EWTX), a Boulder-based muscle disease biopharmaceutical company, has reported a net loss for the fourth quarter of 2023, which ended Dec. 31, 2023.
Edgewise reports loss as it continues trials – BizWest bizwest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizwest.com Daily Mail and Mail on Sunday newspapers.